{"id":"https://genegraph.clinicalgenome.org/r/5ea73e64-f7b6-4c04-a8a1-e821a8163700v1.0","type":"EvidenceStrengthAssertion","dc:description":"MFN2 encodes for GTPases on the outer mitochondrial membranes. The gene was first described as the cause of CMT2 in 14 families in 2004 (PMID: 15064763). A subsequent study screened 323 CMT2 patients and identified significant variants in 29 of them; up to 33% of patients with family history of CMT carried a likely pathogenic MFN2 variant (PMID: 16714318).  Chung et al reported 10 pathogenic mutations in 26 patients from 15 families (PMID: 16835246). MFN2 is expressed in the liver and adipose tissues, and is abundantly expressed in the brain. MFN2 is essential for mitochondrial fusion and contact, mitochondrial transport, ER-mitochondrial contact, and is a mediator of cellular autophagy and mitophagy. Two studies have reported semidominant families with axonal motor and sensory neuropathy with pathogenic variants in MFN2 identified through candidate gene sequencing. Phenotype was variable in many studies, even with the same mutation, as some families had optic atrophy, but others did not. Optic atrophy as an additional symptom to CMT2 was first reported in 6 families by Zuchner et al, where three probands carried de novo MFN2 changes (PMID: 16437557). Other phenotypes reported included periventricular and subcortical hyperintense lesions by brain MRI in eight patients, sensorineural hearing loss in three patients, and bilateral extensor plantar responses in two patients. The role of MFN2 with mitochondrial function, shape, mobility and fusion has been supported with experimental functional studies (Baloh et al, 2007, PMID: 17215403; Chen et al, 2003, PMID: 12527753). In summary, MFN2 is DEFINITIVELY associated with semidominant axonal hereditary motor and sensory neuropathy due to the presence of both genetic case level evidence and experimental evidence.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5ea73e64-f7b6-4c04-a8a1-e821a8163700","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2022-10-10T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2022-10-10T19:18:19.054Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd411105-191f-48c9-9c39-9393027f80bc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a545c02f-0e28-4395-a919-0814a1c6301f","type":"Finding","dc:description":"MFN2R94Q mice showed a weaker grip strength, wobbling gait defect and occasionally dragged their hind limbs which mimic sensorimotor deficits seen in CMT2A patients\nGiven that some CMT2A patients have optic atrophy and vision loss, we examined response\nto visual stimulation on optokinetic response (OKR) testing and\nfound that MFN2R94Q mice also had severe vision loss","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30882371","rdfs:label":"behavioral analysis, Immunohistochemistry aND IMAGING","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ba644aac-4a6e-496e-b317-2d5295eab030","type":"EvidenceLine","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19cd42a5-dff5-4809-a8af-0495825eda7c","type":"Finding","dc:description":"Altered mitochondrial network in cells obtained from CMT2A patients is similar changes seen in morphologies of mitochondria of the mutant flies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29898954","rdfs:label":"Mitochondrial Morphology","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/41c86a94-ec72-49d5-bd90-72cc88aa9cc5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9896d1e1-672b-442f-b0d2-530155ff13fc","type":"Finding","dc:description":"Explanation of how model system phenotype is similar to phenotype observed in humans\tImpairment in the locomotive activities in flies mimics the sensorimotor deficits, with motor dysfunction being the predominant feature, in CMT2A patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30030216","rdfs:label":"Locomotor behavior, mitochondrial morphology, and function","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e86fd3c7-c70d-4722-9a28-c4193ddf906f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d485dc80-e8af-43e3-b0d5-2ad83d6db98a","type":"FunctionalAlteration","dc:description":"abnormal mitochondrial clustering and morphology in cell bodies and proximal axons","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17215403","rdfs:label":"Mitochondrial morphology in MFN2 Mutant expressing DRGs"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aaf746b7-dd47-4aa2-8e33-9d2547f1cd29","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/993c2a21-ae1d-4684-8c70-6bb5e1389d91","type":"FunctionalAlteration","dc:description":"Leading to smaller spherical, and fragmented mitochondria where there's a lack of directed\nmovement in most mitochondria.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12527753","rdfs:label":"Mitochondrial dynamics and morphology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/88eab75d-69d3-488d-b861-0c8be616cca3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1daf47aa-2f58-4681-a665-9e963974a397","type":"FunctionalAlteration","dc:description":"abnormal axonal mitochondrial mobility, stationary clusters of mitochondria, with fewer moving mitochondria","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17215403","rdfs:label":"Mitochondrial mobility in MFN2 mutant expressing cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b92f990a-ad75-466c-b03b-91e35aafcd33","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e80e6b45-f319-4d8e-8447-eb569a17a167","type":"FunctionalAlteration","dc:description":"Two ovoid mitochondria contact each other but do not fuse until much later. Unfused mitochondria","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12527753","rdfs:label":"Mitochondrial fusion assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/edb5e2d8-ea2a-424d-b790-99bc6836a87a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71774ddb-f7a9-4fed-9978-41e1acd0d487","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71774ddb-f7a9-4fed-9978-41e1acd0d487_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16714318","allele":{"id":"https://genegraph.clinicalgenome.org/r/872b6235-fbce-4d30-8628-4871684cbad3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014874.4(MFN2):c.368C>T (p.Pro123Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/637753"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/edb5e2d8-ea2a-424d-b790-99bc6836a87a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16714318","rdfs:label":"PN-930.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/872b6235-fbce-4d30-8628-4871684cbad3"},"detectionMethod":"PCR amplified all 17 coding exons of MFN2 using intronic primers.","firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/71774ddb-f7a9-4fed-9978-41e1acd0d487_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fdb33d22-1f30-49b6-ba5f-0b1c8058e82a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd4559b4-decb-4caf-af28-7a6244745799","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd4559b4-decb-4caf-af28-7a6244745799_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215088","allele":{"id":"https://genegraph.clinicalgenome.org/r/febfa784-bfd4-44ca-ae21-28f5788b8b8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014874.4(MFN2):c.1894C>T (p.Arg632Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA599268"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fdb33d22-1f30-49b6-ba5f-0b1c8058e82a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215088","rdfs:label":"Japasene","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":41,"allele":{"id":"https://genegraph.clinicalgenome.org/r/febfa784-bfd4-44ca-ae21-28f5788b8b8e"},"detectionMethod":"DNA analysis of 60 genes associated with CMT","firstTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bd4559b4-decb-4caf-af28-7a6244745799_variant_evidence_item"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/af9e1f51-1b13-447f-99d5-dd849a27711a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f0cf3e0-66eb-4b8c-bb87-26fa6c14cdf6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f0cf3e0-66eb-4b8c-bb87-26fa6c14cdf6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22189565","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5285d1a-9510-44a3-94d6-fe97c97cdb76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001127660.1(MFN2):c.629A>T (p.Asp210Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338437875"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/af9e1f51-1b13-447f-99d5-dd849a27711a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22189565","rdfs:label":"patient 1-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5285d1a-9510-44a3-94d6-fe97c97cdb76"},"detectionMethod":"Sequencing was done PCR products of the following genes: POLG1, SLC25A4, PEO1, OPA1, POLG2, RRM2B, and MFN2.","firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f0cf3e0-66eb-4b8c-bb87-26fa6c14cdf6_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8f7f9d01-c50c-4bc6-9679-aed241aa4347_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/760be5a8-e355-414f-b0d2-def7bbee0fed","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/760be5a8-e355-414f-b0d2-def7bbee0fed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26955893","allele":{"id":"https://genegraph.clinicalgenome.org/r/a99569d3-368c-4421-8863-0318b3d4c019","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014874.4(MFN2):c.392A>G (p.Asn131Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA598814"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8f7f9d01-c50c-4bc6-9679-aed241aa4347","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26955893","rdfs:label":"Diaphragmatic Weaknes","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a99569d3-368c-4421-8863-0318b3d4c019"},"detectionMethod":"Next-generation sequencing (NGS) analysis of 29 genes was performed and included AARS, BSCL2, DNM2, EGR2, FGD4, FIG4, GARS, GDAP1, GJB1, HSPB1, HSPB8, KIF1B, LITAF, LMNA, MED25, MFN2, MPZ, MTMR2, NDRG1, NEFL, PMP22, PRPS1, PRX, RAB7A, SBF2, SH3TC2, SPG20, TRPV4, and YARS.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Nerve conduction studies showed severe motor>sensory axonal neuropathy with no responses in the lower extremities and needle electromyography showed diffuse denervation. Respiratory compromise with retractions and abdominal breathing. Poor weight gain, prominent tremor in the head and extremities. vomiting,\ngastrointestinal dysmotility, failure to thrive, repeated pulmonary infections, and a sleep disorder.","previousTesting":true,"previousTestingDescription":"Spinal\nmuscular atrophy gene testing was negative and creatine phosphokinase\nwas normal. The results of additional metabolic and genetic\ntesting, which included urine organic acids, plasma amino acids,\nplasma acylcarnitine profile, free and total carnitine, serum biotinidase,\nand microarray, were unrevealing.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/760be5a8-e355-414f-b0d2-def7bbee0fed_variant_evidence_item"},"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a04350b3-5fe9-438a-9e90-db0055ed15e7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81ae8ceb-f93e-4d83-b626-4f579d4be4db_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16835246","rdfs:label":"FC169","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/81ae8ceb-f93e-4d83-b626-4f579d4be4db","type":"Family","rdfs:label":"FC169","member":{"id":"https://genegraph.clinicalgenome.org/r/6e2e4370-6a2c-4ff1-a672-1c49ef8c6be2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16835246","rdfs:label":"FC169-3-6","allele":{"id":"https://genegraph.clinicalgenome.org/r/43f339ae-a3e5-4443-8b71-d4ce00d869d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014874.3(MFN2):c.839G>A (p.Arg280His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252151"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/14909149-107d-4d86-9a95-bd9f610fe161_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16835246","allele":{"id":"https://genegraph.clinicalgenome.org/r/43f339ae-a3e5-4443-8b71-d4ce00d869d0"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6e2e4370-6a2c-4ff1-a672-1c49ef8c6be2"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/65494ce7-9e00-4449-8b31-a142df351905_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22189565","rdfs:label":"Tunisian family","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/65494ce7-9e00-4449-8b31-a142df351905","type":"Family","rdfs:label":"Tunisian family","member":{"id":"https://genegraph.clinicalgenome.org/r/af9e1f51-1b13-447f-99d5-dd849a27711a"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"sensory axonal motor neuropathy, sensory and cerebellar ataxia with pyramidal syndrome, generalized areflexia and generalized weakness (Proximal and distal weakness of lower limbs), visual and hearing impairment, optic atrophy","phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/af9e1f51-1b13-447f-99d5-dd849a27711a"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6e2e4370-6a2c-4ff1-a672-1c49ef8c6be2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14909149-107d-4d86-9a95-bd9f610fe161","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14909149-107d-4d86-9a95-bd9f610fe161_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6e2e4370-6a2c-4ff1-a672-1c49ef8c6be2"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.1}],"evidenceStrength":"Definitive","sequence":5191,"specifiedBy":"GeneValidityCriteria9","strengthScore":16.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/FAQpv1bSJXA","type":"GeneValidityProposition","disease":"obo:MONDO_0018775","gene":"hgnc:16877","modeOfInheritance":"obo:HP_0032113"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a04350b3-5fe9-438a-9e90-db0055ed15e7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}